Mark J. Rosenblum
2020 - Flex Pharma
In 2020, Mark J. Rosenblum earned a total compensation of $520.5K as Executive Vice President, Finance and Chief Financial Officer at Flex Pharma, a 19% increase compared to previous year.
Compensation breakdown
| Bonus | $56,800 |
|---|---|
| Option Awards | $126,273 |
| Salary | $265,000 |
| Other | $72,413 |
| Total | $520,486 |
Rosenblum received $265K in salary, accounting for 51% of the total pay in 2020.
Rosenblum also received $56.8K in bonus, $126.3K in option awards and $72.4K in other compensation.
Rankings
In 2020, Mark J. Rosenblum's compensation ranked 10,921st out of 13,090 executives tracked by ExecPay. In other words, Rosenblum earned more than 16.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,921 out of 13,090 | 17th |
Division Manufacturing | 4,662 out of 5,621 | 17th |
Major group Chemicals And Allied Products | 1,934 out of 2,254 | 14th |
Industry group Drugs | 1,694 out of 1,954 | 13th |
Industry Pharmaceutical Preparations | 1,251 out of 1,459 | 14th |
Source: SEC filing on April 27, 2021.
Rosenblum's colleagues
We found one more compensation record of an executive who worked with Mark J. Rosenblum at Flex Pharma in 2020.
2020
David Arthur
Flex Pharma